COMPASS Pathways plc
COMPASS Pathways plc (CMPS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmps · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for COMPASS Pathways plc (CMPS) measures how much investors pay for each dollar of the company's trailing earnings. CMPS's current PE ratio of N/A is calculated by dividing its stock price of $12.11 by its TTM earnings per share of -$1.63.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
COMPASS Pathways plcYou CMPS | $1.2B | N/A | — | -$1.63 |
 Avanos Medical, Inc. AVNS | $1.2B | N/A | — | -$1.46 |
 Community Health Systems, Inc. CYH | $386M | 0.82x | — | $3.80 |
 Enhabit, Inc. EHAB | $707M | N/A | — | -$0.09 |
 4D Molecular Therapeutics, Inc. FDMT | $452M | N/A | — | -$2.42 |
 Gossamer Bio, Inc. GOSS | $41M | N/A | — | -$0.75 |
 KalVista Pharmaceuticals, Inc. KALV | $1.4B | N/A | — | -$3.23 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-3.08 | — | |
2024-12-31 FY2024 | — | $-2.30 | — | |
2023-12-31 FY2023 | — | $-2.32 | — | |
2022-12-31 FY2022 | — | $-2.16 | — | |
2021-12-31 FY2021 | — | $-1.79 | — | |
2020-12-31 FY2020 | — | $-1.69 | — | |
2019-12-31 FY2019 | — | $-0.90 | — | |
2018-12-31 FY2018 | — | $-2.35 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for COMPASS Pathways plc (CMPS) measures how much investors pay for each dollar of the company's trailing earnings. CMPS's current PE ratio of N/A is calculated by dividing its stock price of $12.11 by its TTM earnings per share of -$1.63.
Frequently asked questions
CMPS pe ratio · 6 questionsCMPS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $12.11 and TTM EPS of -$1.63. Data sourced from Financial Modeling Prep via CMPS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · COMPASS Pathways plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08